Brand-name GLP-1 medications
| Medication | Active ingredient | Maker | Forms |
|---|---|---|---|
| Wegovy | semaglutide | Novo Nordisk | Weekly pen (0.25–2.4 mg), Wegovy HD pen (7.2 mg), daily pill (1.5, 4, 9, 25 mg) |
| Zepbound | tirzepatide | Eli Lilly | Weekly injection: single-dose vials and KwikPen; doses 2.5–15 mg |
| Ozempic | semaglutide | Novo Nordisk | Weekly pen; doses 0.25, 0.5, 1 and 2 mg |
| Foundayo | orforglipron | Eli Lilly | Daily pill: 0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg |
Compounded GLP-1s are not FDA-approved. They are not equivalent to the brand-name medicines on this page.
Comparisons
- Semaglutide vs tirzepatide: How Wegovy and Zepbound differ in how they work, results, side effects and price.
- Wegovy vs Ozempic: Why two semaglutide brands exist, how their doses and approved uses differ, and what each costs to self-pay.
- GLP-1 pills compared: The two FDA-approved weight-loss pills compared on dosing, results, price and how to get them.
- Zepbound vials vs pens: How the two Zepbound formats differ in price, how you inject them and whether insurance applies.
- Compounded vs brand-name: Where compounded semaglutide and tirzepatide stand with the FDA, and what it means for telehealth patients.
More
- GLP-1 glossary: plain-English definitions of common terms.
- GLP-1 side effects
- Price tracker
GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.